Thus, enhancement of DNA damage repair, for instance by (not yet existing) small molecules activating SNEVPrp19/Pso4, could potentially mitigate the accumulation of senescent cells upon aging or cancer therapy with cytotoxic compounds. The gene discussed is PRPF19; the disease is cancer.